NO961724L - Transdermal administreringsform av nitroglycerin for å forhindre uönskede veer - Google Patents
Transdermal administreringsform av nitroglycerin for å forhindre uönskede veerInfo
- Publication number
- NO961724L NO961724L NO961724A NO961724A NO961724L NO 961724 L NO961724 L NO 961724L NO 961724 A NO961724 A NO 961724A NO 961724 A NO961724 A NO 961724A NO 961724 L NO961724 L NO 961724L
- Authority
- NO
- Norway
- Prior art keywords
- pct
- nitroglycerin
- transdermal administration
- prevent unwanted
- sec
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Botany (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4406332A DE4406332C1 (de) | 1994-02-28 | 1994-02-28 | Pharmazeutische Verwendung von Nitroglycerin zur Verhinderung unerwünschter Wehentätigkeit bei Säugern in einer transdermalen Applikationsform |
PCT/EP1995/000654 WO1995022964A1 (de) | 1994-02-28 | 1995-02-23 | Transdermale darreichungsform von nitroglycerin zur verhinderung unerwünschter wehentätigkeit |
Publications (2)
Publication Number | Publication Date |
---|---|
NO961724D0 NO961724D0 (no) | 1996-04-29 |
NO961724L true NO961724L (no) | 1996-04-29 |
Family
ID=6511303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO961724A NO961724L (no) | 1994-02-28 | 1996-04-29 | Transdermal administreringsform av nitroglycerin for å forhindre uönskede veer |
Country Status (15)
Country | Link |
---|---|
US (1) | US5817697A (fi) |
EP (1) | EP0804176B1 (fi) |
JP (1) | JP2823700B2 (fi) |
KR (1) | KR100334372B1 (fi) |
CN (1) | CN1069522C (fi) |
AT (1) | ATE200732T1 (fi) |
CA (1) | CA2184201A1 (fi) |
DE (2) | DE4406332C1 (fi) |
DK (1) | DK0804176T3 (fi) |
ES (1) | ES2156938T3 (fi) |
FI (1) | FI963329A (fi) |
GR (1) | GR3035785T3 (fi) |
NO (1) | NO961724L (fi) |
PT (1) | PT804176E (fi) |
WO (1) | WO1995022964A1 (fi) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020015951A1 (en) * | 2000-01-06 | 2002-02-07 | Bader Joel S. | Method of analyzing a nucleic acid |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU560710B2 (en) * | 1983-04-27 | 1987-04-16 | Lohmann Gmbh & Co. Kg. | Pharmaceutical product |
DE4020144A1 (de) * | 1990-06-25 | 1992-01-09 | Lohmann Therapie Syst Lts | Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen |
ATE126434T1 (de) * | 1991-06-10 | 1995-09-15 | Sanol Arznei Schwarz Gmbh | Nitroglycerin-pflaster und verfahren zu seiner herstellung. |
US5508045A (en) * | 1992-10-09 | 1996-04-16 | The Regents Of The University Of California | Method and agents for control and management of labor during pregnancy |
JPH1192367A (ja) * | 1997-09-22 | 1999-04-06 | Hoechst Marion Roussel Kk | 妊娠悪阻治療剤 |
-
1994
- 1994-02-28 DE DE4406332A patent/DE4406332C1/de not_active Expired - Fee Related
-
1995
- 1995-02-22 US US08/700,402 patent/US5817697A/en not_active Expired - Fee Related
- 1995-02-23 KR KR1019960702455A patent/KR100334372B1/ko not_active IP Right Cessation
- 1995-02-23 DK DK95911253T patent/DK0804176T3/da active
- 1995-02-23 EP EP95911253A patent/EP0804176B1/de not_active Expired - Lifetime
- 1995-02-23 WO PCT/EP1995/000654 patent/WO1995022964A1/de active IP Right Grant
- 1995-02-23 CN CN95191680A patent/CN1069522C/zh not_active Expired - Fee Related
- 1995-02-23 DE DE59509223T patent/DE59509223D1/de not_active Expired - Fee Related
- 1995-02-23 CA CA002184201A patent/CA2184201A1/en not_active Abandoned
- 1995-02-23 PT PT95911253T patent/PT804176E/pt unknown
- 1995-02-23 AT AT95911253T patent/ATE200732T1/de not_active IP Right Cessation
- 1995-02-23 JP JP7522126A patent/JP2823700B2/ja not_active Expired - Fee Related
- 1995-02-23 ES ES95911253T patent/ES2156938T3/es not_active Expired - Lifetime
-
1996
- 1996-04-29 NO NO961724A patent/NO961724L/no not_active Application Discontinuation
- 1996-08-27 FI FI963329A patent/FI963329A/fi not_active IP Right Cessation
-
2001
- 2001-04-26 GR GR20010400584T patent/GR3035785T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2823700B2 (ja) | 1998-11-11 |
NO961724D0 (no) | 1996-04-29 |
CN1140990A (zh) | 1997-01-22 |
FI963329A0 (fi) | 1996-08-27 |
DE4406332C1 (de) | 1995-06-22 |
PT804176E (pt) | 2001-08-30 |
EP0804176B1 (de) | 2001-04-25 |
WO1995022964A1 (de) | 1995-08-31 |
FI963329A (fi) | 1996-09-05 |
CN1069522C (zh) | 2001-08-15 |
EP0804176A1 (de) | 1997-11-05 |
GR3035785T3 (en) | 2001-07-31 |
DE59509223D1 (de) | 2001-05-31 |
DK0804176T3 (da) | 2001-05-28 |
ATE200732T1 (de) | 2001-05-15 |
ES2156938T3 (es) | 2001-08-01 |
KR100334372B1 (ko) | 2002-09-04 |
CA2184201A1 (en) | 1995-08-31 |
JPH09506108A (ja) | 1997-06-17 |
US5817697A (en) | 1998-10-06 |
KR960705553A (ko) | 1996-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO963053L (no) | Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav | |
DK0799209T3 (da) | Sulfonamider | |
BR9909358A (pt) | Composto, composição farmacêutica, e, processo para prevenção ou alìvio de complicações crÈnicas decorrentes de diabetes melito | |
ATE179976T1 (de) | Neue 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazol-derivate | |
CA2254061A1 (en) | Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases | |
AR006401A1 (es) | Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos. | |
HUP0004780A2 (hu) | Prosztaglandin agonisták felhasználása merevedési rendellenességek vagy impotencia kezelésében | |
BE901301A (fr) | 5-pyrimidine-carboxamides et thiocarboamides, ainsi que le traitement de la leucemie et des tumeurs avec ces substances. | |
IL113024A (en) | Quinazolinyl-amino derivatives having alpha-antagonist activity their preparation and pharmaceutical compositions comprising them | |
FR2639225B1 (fr) | Compositions pharmaceutiques pour la neuroprotection contenant des arylcyclohexylamines | |
NO961724D0 (no) | Transdermal administreringsform av nitroglycerin for å forhindre uönskede veer | |
ES2182975T3 (es) | Nueva quimica heterociclica. | |
NO943567L (no) | Bruede bis-arylcarbinolderivater, preparater og anvendelsesmetoder | |
ATE173922T1 (de) | 2-arylpropionsäure-zubereitungen und verfahren zu ihrer herstellung | |
MX9206138A (es) | Procedimiento para preparar (s) (+)-4-4'-(1-metil-1-2-etanodiilo)-bis(2,6-piperazinodiona). | |
KR920003970A (ko) | 혈중 요산 함량의 강하 방법 | |
KR900701273A (ko) | 진토성 에르골린 유도체 | |
DE59504643D1 (de) | Neue phosphanoxide, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel | |
KR950700063A (ko) | 외상후 스트레스 치료제로서의 브로파로민(Brofaromine as an agent for treating post-traumatic stress) | |
KR970702054A (ko) | 헬리코박터 파이로리에 기인한 위장 기능장해 치료를 위한 스피라마이신의 용도(use of spiramycin for treating gastrointestinal disorders caused by h. pylori) | |
KR910011258A (ko) | 녹내장의 치료방법 | |
ES402468A1 (es) | Un procedimiento para la preparacion de vincamina y compuestos semejantes | |
RS49717B (sr) | Terapeutska injektibilna analgetska farmaceutska kompozicija nimesulida za intramuskularno davanje i postupak za njeno dobijanje |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |